Zodryl DEC 60 is a Oral Suspension in the Human Otc Drug category. It is labeled and distributed by Codadose, Inc.. The primary component is Pseudoephedrine Hydrochloride; Codeine Phosphate; Guaifenesin.
Product ID | 43378-125_980d54c0-8941-4180-8952-9ae39c5130b3 |
NDC | 43378-125 |
Product Type | Human Otc Drug |
Proprietary Name | Zodryl DEC 60 |
Generic Name | Codeine Phosphate, Guaifenesin And Pseudoephedrine Hydrochloride |
Dosage Form | Suspension |
Route of Administration | ORAL |
Marketing Start Date | 2009-08-24 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part341 |
Labeler Name | CodaDose, Inc. |
Substance Name | PSEUDOEPHEDRINE HYDROCHLORIDE; CODEINE PHOSPHATE; GUAIFENESIN |
Active Ingredient Strength | 30 mg/7.5mL; mg/7.5mL; mg/7.5mL |
DEA Schedule | CV |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2009-08-24 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph final |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Billing Unit | ML |
Marketing Start Date | 2009-08-24 |
Inactivation Date | 2019-10-21 |
Ingredient | Strength |
---|---|
PSEUDOEPHEDRINE HYDROCHLORIDE | 30 mg/7.5mL |
SPL SET ID: | 0e13fb71-49cc-4989-8a55-77d0d9d1eea0 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
43378-125 | Zodryl DEC 60 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
43378-120 | Zodryl DEC 25 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
43378-121 | Zodryl DEC 30 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
43378-123 | Zodryl DEC 40 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
43378-124 | Zodryl DEC 50 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
43378-126 | Zodryl DEC 80 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |